Comparative Effectiveness Bill Allows Industry Input Into Study Selection
This article was originally published in The Gray Sheet
Executive Summary
A bill introduced in the House May 19 would prevent the government from being the sole director of comparative effectiveness research by setting up an independent institute overseen by a broad array of stakeholders, including industry
You may also be interested in...
Long-Time HELP Democrat Sen. Barbara Mikulski Plans To Retire By 2017
Maryland Sen. Barbara Mikulski (D), the body’s longest-serving female Senator, former Appropriations Committee Chair and advocate of quality and comparative effectiveness provisions in the Affordable Care Act, recently announced her plans not to seek re-election in 2016 and retire.
Comparative Effectiveness Research Gets $1.1 Bil.; How Will Data Be Used?
The massive economic stimulus package expected to be signed by President Obama Feb. 16 includes $1.1 billion to promote comparative effectiveness research, but is vague as to what exactly should be studied and how the results should be used
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.